DSP and autoimmune thrombocytopenic purpura: If IVIG from a certain sexual plasma source had better therapeutic effects on ITP, or if different DSP-IVIG had disparate advantages in the treatment of various diseases, the clinical dosage of IVIG can be optimized, and then the supply and demand of blood products can be alleviated.